UBS Group
GMED icon

UBS Group’s Globus Medical GMED Stock Holding History

UBS Group’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-213,100
Closed -$18.6M – 10754
2025
Q4 		$18.6M Buy
+213,100
New +$16.2M ﹤0.01% 2649

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group's GMED Position: Q1 2026 in Review

UBS Group increased its Globus Medical (GMED) stake by 60% in Q1 2026, buying an estimated $18.3M and bringing the position to 543,112 shares worth $46.8M. The position accounts for 0.01% of the portfolio, ranked #1709.

UBS Group first reported a position in GMED in Q4 2014 and has held it in 46 quarters since. The position peaked at $73.8M in Q1 2025. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • UBS Group held 543,112 shares of Globus Medical worth $46.8M as of Q1 2026.
  • UBS Group bought 203,840 Globus Medical shares in Q1 2026, an estimated $18.3M.
  • Globus Medical made up 0.01% of UBS Group's portfolio in Q1 2026, its #1709 holding.
  • UBS Group first reported a position in Globus Medical in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Globus Medical position peaked at $73.8M in Q1 2025.
  • 602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.